Literature DB >> 2749104

Rise in the incidence of viral hepatitis in Israel despite improved socioeconomic conditions.

M S Green1, C Block, P E Slater.   

Abstract

The incidence of viral hepatitis (mostly type A) in Israel, an area highly endemic for the disease, was examined between 1951 and 1985. During a period of improved standards of living, the overall reported incidence of the disease increased. In the Jewish population, the age of peak incidence shifted from 1-4 y to 5-9 y; this change is compatible with improved sanitation. However, whereas the absolute incidence declined among children 1-4 y old, it doubled among those 5-9 y old over the same period. The peak incidence in the non-Jewish population remains in children 1-4 y old. One possible explanation for the rise in overall incidence is an increase in the ratio of clinical to subclinical infections due to a shift of peak incidence to an older age group. Seasonal patterns have persisted against a background of changing morbidity, with the maximal incidence from late summer to midwinter. An unexplained, consistent excess incidence among males is observed for all age groups.

Entities:  

Mesh:

Year:  1989        PMID: 2749104     DOI: 10.1093/clinids/11.3.464

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  8 in total

1.  New vaccines against hepatitis A enter the market--but who should be vaccinated?

Authors:  S Iwarson
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

2.  Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.

Authors:  G M Ginsberg; D Shouval
Journal:  J Epidemiol Community Health       Date:  1992-12       Impact factor: 3.710

Review 3.  Clinical development of a new inactivated hepatitis A vaccine.

Authors:  E Vidor; B Fritzell; S Plotkin
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

4.  Decline of hepatitis A antibodies during the first 7 months of life in full-term and preterm infants.

Authors:  N Linder; Y Karetnyi; Y Gidony; R Dagan; G Ohel; E Levin; E Mendelson; A Barzilai
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

5.  Molecular characterization of hepatitis A virus isolated from acute gastroenteritis patients in the Seoul region of Korea.

Authors:  S-H Park; E-J Kim; J-H Lee; S-S Choi; M-S Kim; S-S Jung; G-Y Han; H-S Yun; D-S Chun; S-S Oh; H-S Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-26       Impact factor: 3.267

6.  Routine testing for IgG antibodies against hepatitis A virus in Israel.

Authors:  Noah Samuels
Journal:  BMC Public Health       Date:  2005-06-06       Impact factor: 3.295

7.  Seasonality of hepatitis: a review update.

Authors:  Auda Fares
Journal:  J Family Med Prim Care       Date:  2015 Jan-Mar

8.  Hepatitis E as a cause of adult hospitalization in Bangladesh: Results from an acute jaundice surveillance study in six tertiary hospitals, 2014-2017.

Authors:  Repon C Paul; Arifa Nazneen; Kajal C Banik; Shariful Amin Sumon; Kishor K Paul; Arifa Akram; M Salim Uzzaman; Tahir Iqbal; Alexandra Tejada-Strop; Saleem Kamili; Stephen P Luby; Heather F Gidding; Andrew Hayen; Emily S Gurley
Journal:  PLoS Negl Trop Dis       Date:  2020-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.